Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG) exp Degrader in Myotonic Dystrophy
ACS Central Science · 26.07.2023 · 9 (7) · 1342-1353
DOI: 10.1021/acscentsci.2c01223 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 26.06.2023. Verfasst von Quentin M R Gibaut und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Chemistry, UF Scripps Biomedical Research and The Scripps Research Institute, Jupiter, Florida 33458, United States. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Myotonic dystrophy type 1 (DM1) is caused by a highly structured RNA repeat expansion, r(CUG)exp, harbored in the 3' untranslated region (3' UTR) of dystrophia myotonica protein kinase (DMPK) mRNA and drives disease through a gain-of-function mechanism. A panel of low-molecular-weight fragments capable of reacting with RNA upon UV irradiation was studied for cross-linking to r(CUG)expin vitro, affording perimidin-2-amine diazirine (1) that bound to r(CUG)exp. The interactions between the small molecule and RNA were further studied by nuclear magnetic resonance (NMR) spectroscopy and molecular modeling. Binding of 1 in DM1 myotubes was profiled transcriptome-wide, identifying 12 transcripts including DMPK that were bound by 1. Augmenting the functionality of 1 with cleaving capability created a chimeric degrader that specifically targets r(CUG)exp for elimination. The degrader broadly improved DM1-associated defects as assessed by RNA-seq, while having limited effects on healthy myotubes. This study (i) provides a platform to investigate molecular recognition of ligands directly in disease-affected cells; (ii) illustrates that RNA degraders can be more specific than the binders from which they are derived; and (iii) suggests that repeating transcripts can be selectively degraded due to the presence of multiple ligand binding sites.
Autor:innen und Institutionen
- The Department of Chemistry, UF Scripps Biomedical Research and The Scripps Research Institute, Jupiter, Florida 33458, United States.
- Center for NeuroGenetics, University of Florida, Gainesville, Florida 32610, United States.
- Department of Molecular Genetics & Microbiology, College of Medicine, University of Florida, Gainesville, Florida 32610, United States.
ORCID-Profile: Matthew D Disney
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- Congressionally Directed Medical Research Programs
- National Institutes of Health
Zitieren
APA
Gibaut, Q. M. R., Bush, J. A., Tong, Y., Baisden, J. T., Taghavi, A., Olafson, H., Yao, X., Childs-Disney, J. L., Wang, E. T., & Disney, M. D. (2023). Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG) exp Degrader in Myotonic Dystrophy. ACS Central Science, 9(7), 1342-1353. https://doi.org/10.1021/acscentsci.2c01223
Vancouver
Gibaut QMR, Bush JA, Tong Y, Baisden JT, Taghavi A, Olafson H, et al. Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG) exp Degrader in Myotonic Dystrophy. ACS Central Science. 2023;9(7):1342-1353. doi:10.1021/acscentsci.2c01223
BibTeX
@article{Gibaut2023,
author = {Gibaut, Quentin M R and Bush, Jessica A and Tong, Yuquan and Baisden, Jared T and Taghavi, Amirhossein and Olafson, Hailey and Yao, Xiyuan and Childs-Disney, Jessica L and Wang, Eric T and Disney, Matthew D},
title = {Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG) exp Degrader in Myotonic Dystrophy},
journal = {ACS Central Science},
year = {2023},
volume = {9},
number = {7},
pages = {1342--1353},
doi = {10.1021/acscentsci.2c01223}
}
EUVIMED